Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Francesc, Bosch Albareda"'
Autor:
Olga Benitez Hidalgo, M. Fernanda Martinez Garcia, Agustin Bescos Cabestre, Juan Carlos Juarez Gimenez, Mercedes Gironella Mesa, Francesc Bosch Albareda
Publikováno v:
Clinical Case Reports, Vol 10, Iss 5, Pp n/a-n/a (2022)
Abstract Extended half‐life FIX (EHL‐FIX) concentrates have been developed with the purpose of reducing the frequency of infusions in patients with severe or moderate hemophilia B. We describe the case of a 63‐year‐old patient with severe hem
Externí odkaz:
https://doaj.org/article/6c4f796e17684aa097081fcc4972fbba
Autor:
Luana Schiattone, Michel van Gelder, Jana Zuchnická, Viola Maria Popov, Rosa Collado, Candida Vitale, Marta Coscia, Gloria Iacoboni, Marta Morawska, Amy Christian, Darko Antic, Vojin Vukovic, Jorge Labrador, Elżbieta Kalicińska, Marek Trněný, Anna Puiggros, Biljana Mihaljevic, Gian Matteo Rigolin, Ioannis Kotsianidis, Dimitra Chammou, Francesca Bacchiarri, Alberto Fresa, Niki Stavroyianni, Sara Galimberti, Alicia Enrico, Lydia Scarfò, David Donaldson, Jacopo Olivieri, Cheyenne Pierie, Irina Panovska, Tamar Tadmor, Maria Papaioannou, Kostas Stamatopoulos, Christos Demosthenous, Mohamed A. Yassin, Olga Kalashnikova, Fatih Demirkan, Yair Herishanu, Livio Trentin, Theodoros P. Vassilakopoulos, Volkan Karakuş, Alessandro Gozzetti, Almudena Navarro-Bailón, Maya Koren-Michowitz, Carlota Mayor-Bastida, Eric Tse, Šárka Pospíšilová, Lucrecia Yáñez, Georgios Karakatsoulis, Roberta Murru, Martin Spacek, Rocío García-Serra, Susanne R. Janssen, Robert J. Kreitman, Michael Doubek, Valerio Guarente, Eugene Nikitin, Uttam Kumar Nath, Anastasia Chatzidimitriou, Iliana Konstantinou, Arnon P. Kater, Ivana Milosevic, Annett Schiwitza, Martin Simkovic, Romain Guièze, Zhenshu Xu, Andrea Visentin, Stanislava Maslejova, Rosa Ruchlemer, Ömür Gökmen Sevindik, Gimena Dos Santos, Alberto Lopez-Garcia, Thomas Chatzikonstantinou, Francesc Bosch Albareda, Miguel Alcoceba, E. Minga, Eleftheria Hatzimichael, Elisa Albi, Lukas Smolej, Gianluca Gaidano, Rainer Claus, Antonio Cuneo, Kamel Laribi, Ramona Cassin, Michalis Iskas, Jana Kotašková, Panayiotis Panayiotidis, Tomas Papajik, Ozren Jakšić, Fatima Miras, Paolo Ghia, Maria Efstathopoulou, Luca Inchiappa, Bonnie Kho, Marcos Daniel De Deus Santos, Barbara Dreta, Constantine S. Tam, George Vrachiolias, Münci Yağcı, Blanca Espinet, B V Biderman, Stephen P. Mulligan, Zadie Davis, Svetlana Smirnova, David Oscier, Juan Marquet Palomanes, Liat Tourjeman, Sofia Chatzileontiadou, Maria Dimou, Riccardo Moia, Isabel González-Gascón y Marín, Anne Calleja, Kristina Tomic, Ilana Levy, Mehreen Ali Khan, Gerasimos Pangalis, Sean Harrop, Thérèse Aurran, Paolo Sportoletti, Dina Sameh Soliman, Shaimaa El-Ashwah, Maria K. Angelopoulou, Gianluigi Reda, Fatiha Merabet, Yandong Shen, Mark Catherwood, Luca Laurenti, Thomas Longval, Deepesh Lad
The use of novel small molecule inhibitors alone or in combination with anti-CD20 monoclonal antibodies for chronic lymphocytic leukemia (CLL) has raised a number of questions on efficacy, tolerability, long-term treatment adherence in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7a9f4cccd98d74d74691a8db760f3b4
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/98560
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/98560
Autor:
Alessia Bottos, María José Terol, Paolo Corradini, Thomas Stauffer Larsen, Gila Sellam, Antonio Rueda Dominguez, Anna Sureda, David Carlile, Giuseppe Gritti, Anesh Panchal, Audrey Filézac de L'Étang, Francesc Bosch Albareda, Maneesh Tandon, Martin Hutchings, Yanjie Wang
Publikováno v:
Hutchings, M, Terol, M J, Bosch Albareda, F, Corradini, P, Larsen, T S, Dominguez, A R, Panchal, A, Bottos, A, Carlile, D, Wang, Y, Filézac De L'Étang, A, Tandon, M, Sellam, G & Gritti, G 2021, ' Glofitamab (Glofit) in Combination with Polatuzumab Vedotin (Pola): Phase Ib/II Preliminary Data Support Manageable Safety and Encouraging Efficacy in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) ', Blood, vol. 138, no. Supplement 1, 525 . https://doi.org/10.1182/blood-2021-148359
Background: Glofit is a novel, CD20xCD3 T-cell-engaging bispecific antibody that provides monovalent binding to CD3 on T cells and bivalent binding to CD20 on B cells. As monotherapy, Glofit has shown promising response rates with manageable safety i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f2921078c2fa50226647e1e33c306c1
https://portal.findresearcher.sdu.dk/da/publications/13a1d0e6-f3f3-475a-8d60-f08b91de6c6b
https://portal.findresearcher.sdu.dk/da/publications/13a1d0e6-f3f3-475a-8d60-f08b91de6c6b
Autor:
Michael Schaffer, Sriram Balasubramanian, A. Burhan Ferhanoglu, Shean-Sheng Wang, Joshua Brody, María Dolores Caballero Barrigón, Behzad Kharabi Masouleh, Francesc Bosch Albareda, John Alvarez, Aisha Masood, Nele Fourneau, Anas Younes, Arnon Nagler, Cecilia Carpio, Armando López-Guillermo, Michael Streit, Muhit Ozcan, Wojciech Jurczak, Rob Ceulemans, Dina Ben-Yehuda, Irit Avivi
Publikováno v:
Blood. 130:833-833
Background: Preclinical studies have demonstrated synergistic antitumor activity when immune checkpoint inhibitors targeting the programmed cell death protein-1 (PD-1)/PD ligand-1 (PD-L1) axis were combined with the Bruton's tyrosine kinase inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d68491b22b5b9435adc56c9b946fc84b
https://doi.org/10.1182/blood.v130.suppl_1.833.833
https://doi.org/10.1182/blood.v130.suppl_1.833.833
Autor:
José A, García Marco, Pilar, Giraldo Castellano, Javier, López Jiménez, Eduardo, Ríos Herranz, José Luis, Sastre Moral, M José, Terol Casterá, Francesc, Bosch Albareda
Publikováno v:
Medicina clinica. 141(4)
Chronic lymphocytic leukemia is the most common chronic lymphoproliferative disorder in Spain. The clinical management of this entity varies widely. Currently, in Spain, there are no national consensus guidelines, such as those published in other cou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ed723b1577bbb42fc7896c6cdcb4c9d
https://pubmed.ncbi.nlm.nih.gov/24378150
https://pubmed.ncbi.nlm.nih.gov/24378150
Autor:
Francesc Bosch Albareda, José Antonio García Marco, José Luis Sastre Moral, Pilar Giraldo Castellano, Javier Jiménez, M. José Terol Casterá, Eduardo Ríos Herranz
Publikováno v:
Medicina Clínica. 141:175.e1-175.e8
Resumen La leucemia linfocitica cronica es el sindrome linfoproliferativo cronico mas frecuente en nuestro pais, existiendo una amplia heterogeneidad en su abordaje clinico. En la actualidad, en Espana no se dispone de guias de consenso nacionales si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdda8b09d694581bfdb2abcd03850a22
https://doi.org/10.1016/j.medcli.2013.04.041
https://doi.org/10.1016/j.medcli.2013.04.041